Literature DB >> 7076817

Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile.

K H Wilson, M J Kennedy, F R Fekety.   

Abstract

Isolation of Clostridium difficile from fecal specimens has been facilitated by the development of a selective and differential medium, cefoxitin-cycloserinefructose agar (CCFA). We substituted 0.1% sodium taurocholate for the 2.5% egg yolk in CCFA and compared the growth of 15 isolates of C. difficile on the resulting medium with growth on conventional CCFA. The taurocholate-containing medium (TCCFA) quantitatively recovered vegetative forms of C. difficile in the same numbers as CCFA medium. Recovery of spores was a mean 1.7 log(10) higher on TCCFA than on CCFA. Thirty-six of 60 patient stool specimens growing C. difficile gave a heavier growth on TCCFA than on CCFA, and 9 failed to yield C. difficile on CCFA. TCCFA detected spores of 75 colony-forming units per ml from artificially inoculated fecal specimens when conventional stool culturing techniques were used. Fluorescence of colonies of C. difficile was more intense on TCCFA than on CCFA. TCCFA was simpler to prepare and, overall, was more sensitive than CCFA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076817      PMCID: PMC272115          DOI: 10.1128/jcm.15.3.443-446.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  [Sodium taurocholate, a germination factor for anaerobic bacterial spores "in vitro" and "in vivo" (author's transl)].

Authors:  P Railbaud; R Ducluzeau; M C Muller; E Sacquet
Journal:  Ann Microbiol (Paris)       Date:  1974 Oct-Nov

2.  Treatment and prevention of antimicrobial agent-induced colitis and diarrhae.

Authors:  W L George; R D Rolfe; S M Finegold
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

3.  Antibiotic-associated colitis: effects of antibiotics on Clostridium difficile and the disease in hamsters.

Authors:  R Fekety; J Silva; R Toshniwal; M Allo; J Armstrong; R Browne; J Ebright; G Rifkin
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

4.  Epidemiology of experimental enterocecitis due to Clostridium difficile.

Authors:  H E Larson; A B Price; S P Borriello
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

5.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

6.  Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis.

Authors:  R Fekety; K H Kim; D H Batts; R A Browne; M A Cudmore; J Silva; R Toshniwal; K H Wilson
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

7.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

  7 in total
  127 in total

1.  Restriction endonuclease analysis of nosocomial isolates of Clostridium difficile.

Authors:  H R Devlin; W Au; L Foux; W C Bradbury
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

2.  Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism.

Authors:  M J Kennedy; P A Volz
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

3.  Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106.

Authors:  Larry K Kociolek; Dale N Gerding; David W Hecht; Egon A Ozer
Journal:  Microbes Infect       Date:  2018-01-31       Impact factor: 2.700

4.  Effective and reduced-cost modified selective medium for isolation of Clostridium difficile.

Authors:  Michelle M Nerandzic; Curtis J Donskey
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

5.  Spore Cortex Hydrolysis Precedes Dipicolinic Acid Release during Clostridium difficile Spore Germination.

Authors:  Michael B Francis; Charlotte A Allen; Joseph A Sorg
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

6.  Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.

Authors:  K A Stellrecht; A A Espino; V P Maceira; S M Nattanmai; S A Butt; D Wroblewski; G E Hannett; K A Musser
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

Review 7.  Clostridium difficile colitis: pathogenesis and host defence.

Authors:  Michael C Abt; Peter T McKenney; Eric G Pamer
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

8.  Clostridium difficile-associated diarrhoea in uremic patients.

Authors:  B Aronsson; P Barany; C E Nord; B Nyström; P Stenvinkel
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

9.  Interaction of Clostridium difficile and Escherichia coli with microfloras in continuous-flow cultures and gnotobiotic mice.

Authors:  K H Wilson; R Freter
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

10.  Criteria for detection of Clostridium difficile toxin production by counterimmunoelectrophoresis.

Authors:  R P Rennie; J M Elliott; M A Nardini; J H Thornley
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.